Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform

Go back to Lantern Pharma and Actuate Therapeutics Announce Research & Development Collaboration Leveraging Lantern's Artificial Intelligence Platform
(NASDAQ: LTRN) Delayed: 1.84 -0.07 (3.66%)
Previous Close $1.91    52 Week High
Open $1.86    52 Week Low
Day High $2.01    P/E N/A 
Day Low $1.83    EPS
Volume 242,572